Free Trial
ASX:AEV

Avenira (AEV) Stock Price, News & Analysis

About Avenira Stock (ASX:AEV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
28,268 shs
Average Volume
N/A
Market Capitalization
A$25.42 million
P/E Ratio
N/A
Dividend Yield
2.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avenira and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AEV Stock News Headlines

Avenira Limited Releases 2025 Annual Report
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

AEV Stock Analysis - Frequently Asked Questions

Avenira Limited (ASX:AEV) posted its quarterly earnings data on Thursday, March, 15th. The company reported $0.00 EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avenira investors own include Galaxy Resources (GXY), Telstra Group (TLS), Verdant Minerals (VRM), Santos (STO), BlueScope Steel (BSL), AVZ Minerals (AVZ) and Australian Vanadium (AVL).

Company Calendar

Last Earnings
3/15/2018
Today
10/16/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Other Industrial Metals & Mining
Sub-Industry
Insurance
Current Symbol
ASX:AEV
CIK
N/A
Fax
N/A
Employees
22,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$2.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-19.87%
Return on Assets
-7.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.14
Quick Ratio
1.38

Sales & Book Value

Annual Sales
A$3.16 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.33
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,700,000,000
Free Float
N/A
Market Cap
A$25.42 million
Optionable
Not Optionable
Beta
2.54
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (ASX:AEV) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners